Genistein Enhances Insulin-Like Growth Factor Signaling Pathway in Human Breast Cancer (MCF-7) Cells

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2351-2359

  Chen, Wen Fang ^a,b   Wong, Man Sau ^a,b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; COLLAGEN; FULVESTRANT; GENISTEIN; INSULIN RECEPTOR SUBSTRATE 1; ISOFLAVONOID; PHYTOESTROGEN; SOMATOMEDIN; SOMATOMEDIN C RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG MECHANISM; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; GENISTEIN; HUMANS; KINETICS; OSMOLAR CONCENTRATION; PHOSPHOPROTEINS; RECEPTOR, IGF TYPE 1; RECEPTORS, ESTROGEN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOMATOMEDINS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 2442497058     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032065     Document Type: Article

References (47)

1. Makiewicz L, Garey J, Adlercreutz H, Gurpide E 1993 In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 45:399-405
2. Ju YH, Allred CD, Allred KF, Karko KL, Doerge DR, Helferich WG 2001 Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J Nutr 131:2957-2962
3. Zava DT, Duwe G 1997 Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27:31-40
4. Allred CD, Allred KF, Ju YH, Virant SM, Helferich WG 2001 Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 61:5045-5050
5. Shao ZM, Wu J, Shen ZZ, Barsky SH 1998 Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 58:4851-4857
6. Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KD, Weinberg CR, Haney AF, Wilcox AJ, Mclachlan JA 1995 Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 80:1685-1690
7. Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I 1994 Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30A:1675-1682
8. Hsieh CY, Santell RC, Haslam SZ, Helferich WG 1998 Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58:3833-3838
9. Dees C, Foster JS, Ahamed S, Wimalasena J 1997 Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ Health Perspect 105(Suppl 3):633-666
10. Santell RC, Kieu N, Helferich WG 2000 Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr 130:1665-1669
11. King RA, Bursill DB 1998 Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in human. Am J Clin Nutr 67:867-872
12. Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL 1997 Estrogen-induced activation of cdk4 and cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-cdk2. J Biol Chem 272:10882-10894
13. Kato S, Masuhiro Y, Watamabe M, Kobayashi Y, Takeyama KI, Endoh H, Yanagisawa J 2000 Molecular mechanism of a cross-talk between oestrogen and growth factor signaling pathways. Genes Cells 5:593-601
14. Stewart AJ, Johnson AM, May FE, Westley BR 1990 Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178
15. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osbome CK, Yee D 1999 Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796
16. Huynh H, Yang X, Pollak M 1996 Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem 271:1016-1021
17. Valentinis B, Baserga R 2001 IGF-I receptor signaling in transformation and differentiation. Mol Pathol 54:133-137
18. LeRoith D, Roberts Jr CT 2003 The insulin-like growth factor system and cancer. Cancer Lett 195:127-137
19. Surmacz E 2000 Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia 5:95-105
20. Turner BC, Haffty BG, Narayanann L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM 1997 Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 57:3079-3083
21. Jackon JG, White MF, Yee D 1998 Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J Biol Chem 273:9994-10003
22. Surmacz E, Burgaud JL 1995 Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clin Cancer Res 1:1429-1436
23. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, Lee AV, Yee D 1997 Insulin-like growth factor binding protein 3 and insulin receptor substrate 1 in breast cancer: correlation with clinical parameters and disease free survival. Clin Cancer Res 3:103-109
24. Denizot F, Kang R 1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277
25. Brunner N, Bronzert D, Vindelov LL, Rygaard K, Spang-Thomsen M, Lippman ME 1989 Effect of growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells growth in vitro and in nude mice. Cancer Res 49:1515-1520
26. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-252
27. Sriussadaporn S, Wong MS, Pike WJ, Favus MJ 1995 Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat. J Bone Miner Res 10:271-280
28. Mattson DL, Bellehumeur TG 1996 Comparison of three chemiluminescent horseradish peroxidase substrates for immunoblotting. Anal Biochem 240: 306-308
29. Diel P, Olff S, Schmidt S, Michna H 2001 Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7. Planta Med 67:510-514
30. Salerno M, Sisci D, Mauro L, Guvakova MA, Ando S, Surmacz E 1999 Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells. Int J Cancer 81:299-304
31. Messina MJ, Loprinzi CL 2001 Soy for breast cancer survivors: a critical review of the literature. J Nutr 131(Suppl 11):3095S-3108S
32. Chen WF, Huang MH, Tzang CH, Yang M, Wong MS 2003 Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophys Acta 1683:187-196
33. Zubik L, Meydani M 2003 Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 77:1459-1465
34. Setchell KD, Brown NM, Desai PB, Zimmer-Nechimias L, Wolfe B, Jakate AS, Creutzinger V, Heubi JE 2003 Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J Nutr 133:1027-1035
35. Molloy CA, May FEB, Westley BR 2000 Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 275:12365-12371
36. Martin MB, Stoica A 2002 Insulin-like growth factor-I and estrogen interactions in breast cancer. J Nutr 132:37995-3801S
37. Mendez P, Azcoitia I, Garcia-Segura LM 2003 Estrogen receptor α forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res 112:170-176
38. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:3867-3873
39. Jordan VC 1994 Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 31:41-52
40. Feng W, Webb P, Nguyen P, Liu X, Li J, Karin M, Kushner PJ 2001 Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway. Mol Endocrinol 15:32-45
41. Margeat E, Bourdoncle A, Margueron R, Poujol N, Cavailles V, Royer C 2003 Ligand differentially modulate the protein interactions of the human estrogen receptor α and β. J Mol Biol 326:77-92
42. Yamamoto Y, Wada O, Suzawa M, Yogiashi Y, Yano T, Kato S, Yanagisawa J 2001 The Tamoxifen-responsive estrogen receptor a mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes. J Biol Chem 276:42684-42691
43. Huynh H, Nickerson T, Pollak M, Yang X 1996 Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res 2:2037-2042
44. Helle SI, Lonning PE 1996 Insulin-like growth factors in breast cancer. Acta Oncol 35(Suppl 5):19-22
45. Guvakova MA, Surmacz E 1997 Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Cancer Res 57:2606-2610
46. Deleted in proof.
47. Brodt P, Samani A, Navab R 2000 Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy. Biochem Pharmacol 60:1101-1107